HTGC Stock - Hercules Capital, Inc.
Unlock GoAI Insights for HTGC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $430.90M | $494.12M | $239.39M | $309.58M | $357.38M |
| Gross Profit | $353.75M | $426.50M | $184.64M | $255.13M | $297.77M |
| Gross Margin | 82.1% | 86.3% | 77.1% | 82.4% | 83.3% |
| Operating Income | $262.97M | $337.48M | $102.08M | $174.16M | $227.26M |
| Net Income | $262.97M | $337.48M | $102.08M | $174.16M | $227.26M |
| Net Margin | 61.0% | 68.3% | 42.6% | 56.3% | 63.6% |
| EPS | $1.61 | $2.32 | $0.80 | $1.50 | $2.02 |
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million to $250 million in equity per transactions. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Connecticut; Boston, Massachusetts; San Diego, California; Westport, Connecticut; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia and London, United Kingdom.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 4th 2025 | Compass Point | Upgrade | Buy | $19.5 |
| December 12th 2024 | Keefe Bruyette | Upgrade | Outperform | $21.5← $19.5 |
| January 16th 2024 | Compass Point | Downgrade | Neutral | $17.5← $17 |
| November 21st 2023 | UBS | Initiation | Neutral | $17 |
| August 30th 2023 | Compass Point | Upgrade | Buy | $17.5 |
| August 4th 2023 | Keefe Bruyette | Upgrade | Market Perform | $17← $13.5 |
| April 6th 2023 | Piper Sandler | Upgrade | Overweight | $16 |
| March 13th 2023 | Keefe Bruyette | Downgrade | Underperform | $10.5← $14.5 |
| July 29th 2022 | Oppenheimer | Downgrade | Perform | - |
| April 22nd 2022 | Keefe Bruyette | Downgrade | Market Perform | $18 |
Earnings History & Surprises
HTGCEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 12, 2026 | $0.48 | — | — | — |
Q4 2025 | Oct 30, 2025 | $0.48 | $0.49 | +2.1% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $0.47 | $0.50 | +6.4% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $0.46 | $0.45 | -2.2% | ✗ MISS |
Q1 2025 | Feb 13, 2025 | $0.51 | $0.49 | -3.9% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $0.51 | $0.51 | 0.0% | = MET |
Q3 2024 | Aug 1, 2024 | $0.51 | $0.51 | 0.0% | = MET |
Q2 2024 | May 2, 2024 | $0.50 | $0.50 | 0.0% | = MET |
Q1 2024 | Feb 15, 2024 | $0.50 | $0.56 | +12.0% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $0.50 | $0.52 | +4.0% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $0.49 | $0.53 | +8.2% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.46 | $0.47 | +2.2% | ✓ BEAT |
Q1 2023 | Feb 16, 2023 | $0.42 | $0.47 | +11.9% | ✓ BEAT |
Q4 2022 | Nov 2, 2022 | $0.36 | $0.39 | +8.3% | ✓ BEAT |
Q3 2022 | Jul 28, 2022 | $0.33 | $0.32 | -3.0% | ✗ MISS |
Q2 2022 | May 5, 2022 | $0.31 | $0.30 | -3.2% | ✗ MISS |
Q1 2022 | Feb 22, 2022 | $0.33 | $0.35 | +6.1% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $0.32 | $0.33 | +3.1% | ✓ BEAT |
Q3 2021 | Jul 29, 2021 | $0.32 | $0.32 | 0.0% | = MET |
Latest News
Compass Point Upgrades Hercules Capital to Buy, Announces $19.5 Price Target
📈 PositiveHercules Capital Q3 EPS $0.49 Beats $0.48 Estimate, Sales $138.100M Beat $135.050M Estimate
📈 PositiveUBS Maintains Neutral on Hercules Capital, Lowers Price Target to $18.5
➖ NeutralPiper Sandler Maintains Overweight on Hercules Capital, Lowers Price Target to $20.5
➖ NeutralUniQure shares are trading higher after the company announced it entered into a $175 million non-dilutive senior secured term loan facility with Hercules Capital.
📈 PositiveuniQure Refinances $50M Debt And Gains Access To Additional $125M Non-Dilutive Funding From Hercules Capital
📈 PositiveSenseonics Holdings Memorandum Of Understanding To Transition All Commercialization And Distribution Of Eversense 365 And Future Products From Ascensia Diabetes Care; Non-dilutive Debt Facility Expanded Up To $100M With Hercules Capital To Fund Commercial Organization
📈 PositiveFrequently Asked Questions about HTGC
What is HTGC's current stock price?
What is the analyst price target for HTGC?
What sector is Hercules Capital, Inc. in?
What is HTGC's market cap?
Does HTGC pay dividends?
Similar Stocks
Financial Services SectorExplore stocks similar to HTGC for comparison